Literature DB >> 33465773

Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson's Disease.

Songzhe He1,2, Shan Zhong3, Gang Liu3, Jun Yang4.   

Abstract

BACKGROUND: Parkinson's disease (PD) is a multifactorial, chronic, and progressive neurodegenerative disease. α-Synuclein (α-syn), which is the main protein component of Lewy bodies, plays an important role in the pathological hallmarks of PD. However, the pathological function of α-syn and the molecular mechanisms responsible for the degeneration of dopaminergic neurons are still elusive.
SUMMARY: Cumulative evidence implicates that abnormal processing of α-syn will be predicted to lead to pathological changes in PD. Key Messages: In this review, we summarize the structure and physiological function of α-syn, and further discuss the interplay of pathology, neuroinflammation, and environmental factors in PD. Additionally, we suggest future directions for understanding the toxicity of α-syn to neurons, which may ultimately encourage us to better design disease-modifying therapeutic strategies for PD.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Environmental factors; Neuroinflammation; Parkinson’s disease; Protein aggregation; α-Synuclein

Year:  2021        PMID: 33465773     DOI: 10.1159/000511083

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  6 in total

Review 1.  Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance.

Authors:  Subhashree Sahoo; Amrita Arpita Padhy; Varsha Kumari; Parul Mishra
Journal:  Mol Neurobiol       Date:  2022-06-14       Impact factor: 5.682

Review 2.  Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 3.  Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches.

Authors:  Marija Vidović; Milena G Rikalovic
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

4.  Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients.

Authors:  Federica Piancone; Marina Saresella; Francesca La Rosa; Ivana Marventano; Mario Meloni; Jorge Navarro; Mario Clerici
Journal:  Front Neurosci       Date:  2021-03-25       Impact factor: 4.677

Review 5.  Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease.

Authors:  Sean J Miller; Cameron E Campbell; Helen A Jimenez-Corea; Guan-Hui Wu; Robert Logan
Journal:  Front Neurosci       Date:  2022-04-19       Impact factor: 5.152

Review 6.  The Effect of Aggregated Alpha Synuclein on Synaptic and Axonal Proteins in Parkinson's Disease-A Systematic Review.

Authors:  Jennifer Murphy; Declan P McKernan
Journal:  Biomolecules       Date:  2022-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.